These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7216154)

  • 1. Phytohemagglutin-induced lymphocyte cytotoxicity in hemodialysis patients with hepatitis B virus infection.
    Huges-Law G; de Gast GC; Houwen B; The TH; Tegzess AM; van der Hem GK
    Hepatogastroenterology; 1981 Apr; 28(2):93-5. PubMed ID: 7216154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes.
    Mondelli M; Vergani GM; Alberti A; Vergani D; Portmann B; Eddleston AL; Williams R
    J Immunol; 1982 Dec; 129(6):2773-8. PubMed ID: 6982941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
    Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
    Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-dependent cell-mediated cytotoxicity (ADCC) and cell-mediated cytotoxicity (CMC) to HBsAg-coated target cells in patients with hepatitis B and chronic hepatitis (CAH).
    Warnatz H; Rösch W; Gerlich W; Gutmann W
    Clin Exp Immunol; 1979 Jan; 35(1):133-40. PubMed ID: 371882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic hepatitis B virus infection via oral immune regulation toward hepatitis B virus proteins.
    Safadi R; Israeli E; Papo O; Shibolet O; Melhem A; Bloch A; Rowe M; Alper R; Klein A; Hemed N; Segol O; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Am J Gastroenterol; 2003 Nov; 98(11):2505-15. PubMed ID: 14638356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
    Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
    Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated immunity in acute and chronic hepatitis.
    Wands JR; Perrotto JL; Alpert E; Isselbacher KJ
    J Clin Invest; 1975 May; 55(5):921-9. PubMed ID: 1079030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: clinical significance.
    Ghisetti V; Marzano A; Zamboni F; Barbui A; Franchello A; Gaia S; Marchiaro G; Salizzoni M; Rizzetto M
    Liver Transpl; 2004 Mar; 10(3):356-62. PubMed ID: 15004761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of intrahepatic HBV-specific cytotoxic T-cells during and after acute HBV infection in humans.
    Sprengers D; van der Molen RG; Kusters JG; De Man RA; Niesters HG; Schalm SW; Janssen HL
    J Hepatol; 2006 Aug; 45(2):182-9. PubMed ID: 16516331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus infection in hemodialysis: recent discoveries.
    Fabrizi F; Lunghi G; Martin P
    J Nephrol; 2002; 15(5):463-8. PubMed ID: 12455711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult hepatitis B virus infection in chronic hemodialysis patients in Korea.
    Gwak GY; Huh W; Lee DH; Min BH; Koh KC; Kim JJ; Oh HY
    Hepatogastroenterology; 2008; 55(86-87):1721-4. PubMed ID: 19102377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro study of IgG production and concanavalin A induced suppressor cell function in acute and chronic hepatitis B virus infection.
    Nouri-Aria KT; Alexander GJ; Portmann B; Vergani D; Eddleston AL; Williams R
    Clin Exp Immunol; 1986 Apr; 64(1):50-8. PubMed ID: 2942323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional properties of lymphocyte subpopulations in hepatitis B virus infection. II. Cytotoxic effector cell killing of targets that naturally express hepatitis B surface antigen and liver-specific lipoprotein.
    Chisari FV; Bieber MS; Josepho CA; Xavier C; Anderson DS
    J Immunol; 1981 Jan; 126(1):45-9. PubMed ID: 6450241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-gamma (IFN-gamma) response to different hepatitis B virus antigens in hepatitis B virus infection.
    Paul S; Tabassum S; Islam MN
    Bangladesh Med Res Counc Bull; 2004 Aug; 30(2):71-7. PubMed ID: 15813485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with Hepatitis B virus.
    Barnaba V; Franco A; Paroli M; Benvenuto R; De Petrillo G; Burgio VL; Santilio I; Balsano C; Bonavita MS; Cappelli G
    J Immunol; 1994 Mar; 152(6):3074-87. PubMed ID: 7511637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus infection in allogeneic bone marrow transplantation.
    Ustün C; Koç H; Karayalcin S; Akyol G; Gürman G; Ilhan O; Akan H; Ozcan M; Arslan O; Konuk N; Uysal A; Beksaç M
    Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus markers among family contacts and medical personnel of 239 hemodialysis patients.
    Gahl GM; Vogl E; Kraft D; Hess G; Arnold W
    Clin Nephrol; 1980 Jul; 14(1):8-12. PubMed ID: 7408256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occult hepatitis B virus infection in hemodialysis patients with chronic HCV infection.
    Siagris D; Christofidou M; Triga K; Pagoni N; Theocharis GJ; Goumenos D; Lekkou A; Thomopoulos K; Tsamandas AC; Vlachojannis J; Labropoulou-Karatza C
    J Nephrol; 2006; 19(3):327-33. PubMed ID: 16874693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An outbreak of fulminant hepatitis B in immunocompromised hemodialysis patients.
    Igaki N; Nakaji M; Moriguchi R; Akiyama H; Tamada F; Oimomi M; Goto T
    J Gastroenterol; 2003; 38(10):968-76. PubMed ID: 14614604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Induction of specific cytotoxic T lymphocyte response against hepatitis B virus by hepatitis B virus S gene-modified dendritic cells].
    Lei CL; Huang CH; Yang Z; Tang XP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):108-10. PubMed ID: 17653306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.